21 May 2010	Abbott recognised once again as one of the UK's Best Workplaces
19 May 2010	Adalimumab Recommended by NICE for Crohn's Disease Sufferers for the First Time in the UK
16 February 2010	Abbott Completes Acquisition of Solvay Pharmaceuticals
10 February 2010	New Heat-Stable Norvir® (ritonavir) Tablet Approved in Europe
21 January 2010	Abbott to Suspend Marketing of Obesity Medicine Sibutramine in European Union Countries
30 September 2009	Abbott Cuts Use of Oil and Coal by 35 Percent
25 September 2009	Abbott Receives European Approval for Once-Daily Dosing of Kaletra® (lopinavir/ritonavir) Tablet
16 September 2009	Abbott expands use of sustainable packaging as part of global environmental efforts
16 July 2009	New research shows the impact of excess weight on self esteem
29 June 2009	Olympic Gold Medallist helps Abbott employees fit fitness into their work lives
22 May 2009	Abbott recognised as one of the UK's Best Work places by the Great Place to Work Institute
11 December 2008	Abbott named one of Britain's Most Admired Healthcare Companies by Management Today
26 August 2008	Clinicians Visit from Africa and Asia to Find Out About UK HIV Practices
25 June 2008	NICE Recommends Abbott's Adalimumab (HUMIRA®) for the Treatment of Chronic Plaque Psoriasis
28 May 2008	NICE Recommends Abbott's Adalimumab (HUMIRA®) for the Treatment of Severe Active Ankylosing Spondylitis
11 March 2008	Abbott UK Rated 'Outstanding' Place to Work
24 August 2007	Abbott Staff Volunteer Team Restores Redlees Play Area
7 July 2007	Abbott Retains Investors in People Standard for Eleventh Year Running
2 November 2006	Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-infected Children in Malawi

For all media enquiries, please contact the Communications department on 01628 644582 or email ukcommunications@abbott.com.